profile-img
Giulio Draetta

@DraettaG

Chief Scientific Officer at The University of Texas MD Anderson Cancer Center, @MDAndersonNews. Cancer researcher, oncology R& D leader. Views are my own.

calendar_today30-03-2013 23:00:39

348 Tweets

1,2K Followers

420 Following

Giulio Draetta(@DraettaG) 's Twitter Profile Photo
Giulio Draetta
@DraettaG

8 months ago

Exciting new results presented at ESMO, from the first randomized trial proving benefit from targeting FGFR3: Erdafitinib treatment in Advanced or Metastatic Urothelial Carcinoma. Congratulations to Arlene Siefker-Radtke and collaborators.

Exciting new results presented at ESMO, from the first randomized trial proving benefit from targeting FGFR3: Erdafitinib treatment in Advanced or Metastatic Urothelial Carcinoma. Congratulations to Arlene Siefker-Radtke and collaborators.
account_circle